SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at...
YY Group Holding (NASDAQ: YYGH) Pauses At-The-Market Offering
CERo Therapeutics Doses Second Patient in Cohort 2 of Phase 1 CER-1236 Trial
Turbo Energy Expects to Report 130%–140% Revenue Growth, Reaching $22.5 – $23.5 Million in 2025 Based on Preliminary Unaudited Results
Giftify’s CardCash Reports 14.2% Sell-Side Volume Growth and 18.5% Rise in New Seller Acquisition Through Early Q1 2026, Expanding Platform Supply Base
